Transcription factor effector domains

Sub-Cellular Biochemistry

Volumn 52, Issue , 2011, Pages 261-277

  Frietze, Seth ^a   Farnham, Peggy J ^b  

^a Department of Biochemistry and Molecular Biology Norris Comprehensive Cancer Center University of Southern California ^*

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATIN; HISTONE; TRANSCRIPTION FACTOR;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROMOTER REGION;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; HISTONES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84883762758     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-90-481-9069-0_12     Document Type: Article

References (114)

1. Park PJ (2009) ChIP-seq: advantages and challenges of a maturing technology. Nature Rev Genet (10):669-680
2. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Human Molecular Genetics 3:1487-1495
3. Farnham PJ (2009) Insights from genomic profiling of transcription factors. Nature Rev Genet (10):605-616
4. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (7146):799-816
5. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM (2009) A census of human transcription factors: function, expression and evolution. Nat Reviews Genetics 10 (4): 252-263
6. Keegan L, Gill G, Ptashne M (1986) Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science 231 (4739):699-704
7. Lin YS, Carey MF, Ptashne M, Green MR (1988) GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell 54 (5):659-664
8. Brent R, Ptashne M (1985) A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell 43 (3 Pt 2):729-736
9. Sasai N, Defossez PA (2009) Many paths to one goal? The proteins that recognize methylated DNA in eukaryotes. Int J Dev Biol 53 (2-3):323-334
10. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N et al. (1998) Methylated DNA and MeCP2 recruit histone deacetylases to repress transcription. Nat Genet 19:187-191
11. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (6683):386-389
12. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP (2003) The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28 (2):69-74
13. Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25 (1):15-30
14. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 14 (11):1025-1040
15. Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC et al. (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410 (6824):120-124
16. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T (2001) Methylation of histone H3 lysine 9 creates abinding site for HP1 proteins. Nature410 (6824):116-120
17. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J et al. (2006) Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 andCrb2 in DNA repair. Cell 127 (7):1361-1373
18. Kim J, Daniel J, Espejo A, Lake A, Krishna M, Xia L et al. (2006) Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep 7 (4):397-403
19. Mujtaba S, Zeng L, Zhou MM (2007) Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26 (37):5521-5527
20. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106 (28):11667-11672
21. Frietze S, O'Geen H, Blahnik KR, Jin VX, Farnham PJ (2010) ZNF274 recruits the histone methyltransferase SETDB1 to the 3' ends of ZNF genes. PLoS One 5 (12):e15082
22. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang X-P, Neilson EG et al. (1996) KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes & Dev 10 (16):2067-2078
23. Sripathy SP, Stevens J, Schultz DC (2006) The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression. Mol Cell Biol 26 (22): 8623-8638
24. Lavery DN, McEwan IJ (2005) Structure and function of steroid receptor AF1 transactiva-tion domains: induction of active conformations. Biochem J 391 (Pt 3):449-464
25. Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE, Prough RA (2001) Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 60 (3):611-619
26. Szapary D, Huang Y, Simons SS. (1999) Opposing effects of corepressor and coacti-vators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol Endocrinol 13 (12):2108-2121
27. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR (2009) DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324 (5925):407-410
28. Thomas MC, Chiang CM (2006) The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 41 (3):105-178
29. Lee TI, Young RA (2000) Transcription of eukaryotic protein-coding genes. Annu Rev Genet 34:77-137
30. Cujec TP, Cho H, Maldonado E, Meyer J, Reinberg D, Peterlin BM (1997) The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoen-zyme. Mol Cell Biol 17 (4):1817-1823
31. Fry CJ, Slansky JE, Farnham PJ (1997) Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol Cell Biol 17(4):1966-1976
32. Gill G, Pascal E, Tseng ZH, Tjian R (1994) A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci USA 91 (1):192-196
33. Goodrich JA, Hoey T, Thut C, Admon A, Tjian R (1993) Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell 75 (3):519-530
34. Horikoshi M, Hai T, Lin YS, Green MR, Roeder RG (1988) Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex. Cell 54 (7):1033-1042
35. Kashanchi F, Piras G, Radonovich MF, Duvall JF, Fattaey A, Chiang CM et al. (1994) Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature 367 (6460):295-299
36. Lin Y-S, Ha I, Maldonado E, Reinberg D, Green MR (1991) Binding of general transcription factor TFIIB to an acidic activating region. Nature 353 (6344):569-571
37. Roberts SG, Choy B, Walker SS, Lin YS, Green MR (1995) A role for activator-mediated TFIIB recruitment in diverse aspects of transcriptional regulation. Curr Biol 5 (5):508-516
38. Stringer KF, Ingles CJ, Greenblatt J (1990) Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature 345 (6278):783-786
39. Zhu H, Joliot V, Prywes R (1994) Role of transcription factor TFIIF in serum response factor-activated transcription. J Biol Chem 269 (5):3489-3497
40. Kim TK, Roeder RG (1994) Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. Proc Natl Acad Sci U S A 91 (10):4170-4174
41. Chiang C-M, Roeder RG (1995) Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267 (5197):531-536
42. Tanese N, Pugh BF, Tjian R (1991) Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev 5:2212-2224
43. Hoey T, Weinzierl RO, Gill G, Chen JL, Dynlacht BD, Tjian R (1993) Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 72 (2):247-260
44. Chen J-L, Attardi DL, Verrijzer CP, Yokomori K, Tjian R (1994) Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79 (1):93-105
45. Blair WS, Bogerd HP, Madore SJ, Cullen BR (1994) Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module. Mol Cell Biol 14 (11):7226-7234
46. Lin J, Chen J, Elenbaas B, Levine AJ (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes & Dev 8 (10):1235-1246
47. Blau J, Xiao H, McCracken S, O'Hare P, Greenblatt J, Bentley D (1996) Three functional classes of transcriptional activation domains. Mol Cell Biol 16 (5):2044-2055
48. Choy B, Green MR (1993) Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature 366 (6455):531-536
49. Krumm A, Hickey LB, Groudine M (1995) Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev 9 (5):559-572
50. Mahanta SK, Scholl T, Yang FC, Strominger JL (1997) Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc Natl Acad Sci U S A 94 (12):6324-6329
51. Yankulov K, Blau J, Purton T, Roberts S, Bentley DL (1994) Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 77 (5):749-759
52. Fuda NJ, Ardehali MB, Lis JT (2009) Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461 (7261):186-192
53. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB et al. (2010) c-Myc regulates transcriptional pause release. Cell 141 (3):432-445
54. Selth LA, Sigurdsson S, Svejstrup JQ (2010) Transcript Elongation by RNA Polymerase II. Annu Rev Biochem 79:271-293
55. Eberhardy SR, Farnham PJ (2002) Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 277 (42):40156-40162
56. Cowling VH, Cole MD (2007) The Myc transactivation domain promotes global phospho-rylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol 27 (6):2059-2073
57. Minezaki Y, Homma K, Kinjo AR, Nishikawa K (2006) Human transcription factors contain a high fraction of intrinsically disordered regions essential for transcriptional regulation. J Mol Biol 359 (4):1137-1149
58. Ayed A, Mulder FA, Yi GS, Lu Y, Kay LE, Arrowsmith CH (2001) Latent and active p53 are identical in conformation. Nat Struct Biol 8 (9):756-760
59. Dawson R, Muller L, Dehner A, Klein C, Kessler H, Buchner J (2003) The N-terminal domain of p53 is natively unfolded. J Mol Biol 332 (5):1131-1141
60. Chi SW, Lee SH, Kim DH, Ahn MJ, Kim JS, Woo JY et al. (2005) Structural details on mdm2-p53 interaction. J Biol Chem 280 (46):38795-38802
61. Uesugi M, Verdine GL (1999) The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2. Proc Natl Acad Sci U S A 96 (26):14801-14806
62. Garza AS, Ahmad N, Kumar R (2009) Role of intrinsically disordered protein regions/domains in transcriptional regulation. Life Sci 84 (7-8):189-193
63. Kumar R, Betney R, Li J, Thompson EB, McEwan IJ (2004) Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochemistry 43 (11):3008-3013
64. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O et al. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18 (17):4608-4618
65. Kumar R, Litwack G (2009) Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain. Steroids 74 (12):877-883
66. Panne D (2008) The enhanceosome. Curr Opin Structural Biol 18 (2):236-242
67. Huber HE, Edwards G, Goodhart PJ, Patrick DR, Huang PS, Ivey-Hoyle M et al. (1993) Transcription factor E2F binds as a heterodimer. Proc Natl Acad Sci USA 90 (8):3525-3529
68. Helin K, Wu C-L, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C et al. (1993) Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative iraws-activation. Genes Dev 7 (10):1850-1861
69. Remenyi A, Lins K, Nissen LJ, Reinbold R, Scholer HR, Wilmanns M (2003) Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev 17 (16):2048-2059
70. Remenyi A, Tomilin A, Scholer HR, Wilmanns M (2002) Differential activity by DNA-induced quarternary structures of POU transcription factors. Biochem Pharmacol 64 (5-6):979-984
71. Kitayner M, Rozenberg H, Rohs R, Suad O, Rabinovich D, Honig B et al. (2010) Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs. Nat Struct Mol Biol 17 (4):423-429
72. Leng X, Blanco J, Tsai SY, Ozato K, O'Malley BW, Tsai MJ (1994) Mechanisms for syner-gistic activation of thyroid hormone receptor and retinoid X receptor on different response elements. J Biol Chem 269 (50):31436-31442
73. Reginato MJ, Zhang J, Lazar MA (1996) DNA-independent and DNA-dependent mechanisms regulate the differential heterodimerization of the isoforms of the thyroid hormone receptor with retinoid X receptor. J Biol Chem 271 (45):28199-28205
74. Jin VX, O'Geen H, Iyengar S, Green R, Farnham PJ (2007) Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches. Genome Research 17 (6):807-817
75. Mathur D, Danford TW, Boyer LA, Young RA, Gifford DK, Jaenisch R (2008) Analysis of the mouse embryonic stem cell regulatory networks obtained by ChIP-chip and ChIP-PET. Genome Biol 9 (8):R126
76. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 (6):1106-1117
77. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH et al. (2005) Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280 (26):24731-24737
78. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693-705
79. Trouche D, Cook A, Kouzarides T (1996) The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res 24 (21):4139-4145
80. Fry CJ, Pearson A, Malinowski E, Bartley SM, Greenblatt J, Farnham PJ (1999) Activation of the murine dihydrofolate reductase promoter by E2F1: A requirement for CBP recruitment. J Biol Chem 274 (22):15883-15891
81. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y (2002) A complex with chro-matin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296 (5570):1132-1136
82. Trimarchi JM, Fairchild B, Wen J, Lees JA (2001) The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci USA 95 (6):2850-2855
83. Attwooll C, Oddi S, Cartwright P, Prosperini E, Agger K, Steensgaard P et al. (2005) A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J Biol Chem 280 (2):1199-1208
84. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, Green R et al. (2007) A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals iterchangeable roles of E2F family members. Genome Res 17 (11):1550-1561
85. Oberley MJ, Inman D, Farnham PJ (2003) E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J Biol Chem 278 (43):42466-42476
86. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-si-ali S, Trouche D (2001) Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltrans-ferase. Mol Cell Biol 21 (19):6484-6494
87. Gonzalo S, Garcia-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE et al. (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7 (4):420-428
88. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nature genetics 25 (3):338-342
89. Pradhan S, Kim G-D (2002) The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity. EMBO J 21:779-788
90. Trojer P, Li G, Sims RJ, 3rd, Vaquero A, Kalakonda N, Boccuni P et al. (2007) L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 129 (5):915-928
91. Trojer P, Reinberg D (2008) Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure. Cell Cycle 7 (5): 578-585
92. Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, Jenuwein T et al. (2009) Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins. J Biol Chem 284 (13):8395-8405
93. Longworth MS, Dyson NJ (2010) pRb, a local chromatin organizer with global possibilities. Chromosoma 119(1):1–11
94. Rosenfeld MG, Lunyak VV, Glass CK (2006) Sensors and signals: a coactiva-tor/corepressor/epigenetic code for integrating signal-dependent programs oftranscriptional response. Genes Dev 20 (11):1405-1428
95. Lee YH, Stallcup MR (2009) Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol Endocrinol 23 (4):425-433
96. Spange S, Wagner T, Heinzel T, Kramer OH (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 41 (1):185-198
97. Lee SK, Kim HJ, Na SY, Kim TS, Choi HS, Im SY et al. (1998) Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem 273 (27):16651-16654
98. Li G, Heaton JH, Gelehrter TD (2006) Role of steroid receptor coactivators in glucocorti-coid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression. Mol Endocrinol 20 (5):1025-1034
99. Gao Z, Chiao P, Zhang X, Lazar MA, Seto E, Young HA et al. (2005) Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem 280 (22): 21091-21098
100. Louie MC, Zou JX, Rabinovich A, Chen HW (2004) ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 24 (12):5157-5171
101. Batsche E, Desroches J, Bilodeau S, Gauthier Y, Drouin J (2005) Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J Biol Chem 280 (20):19746-19756
102. Lee SK, Kim HJ, Kim JW, Lee JW (1999) Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. Mol Endocrinol 13 (11):1924-1933
103. Belandia B, Parker MG (2003) Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114 (3):277-280
104. Privalsky ML (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360
105. Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, Bardwell V et al. (2002) Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol 22 (6):1804-1818
106. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J (2003) N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 12 (3):723-734
107. Muto A, Hoshino H, Madisen L, Yanai N, Obinata M, Karasuyama H et al. (1998) Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer. EMBO J 17 (19):5734-5743
108. Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, Leutz A et al. (1997) Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci US A 94 (20):10762-10767
109. Kelly KF, Daniel JM (2006) POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 16 (11):578-587
110. Urrutia R (2003) KRAB-containing zinc-finger repressor proteins. Genome Biol 4 (10):231
111. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ, 3rd (2002) SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16 (8):919-932
112. Schultz DC, Friedman JR, Rauscher F (2001) Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PhD and bromodomains of KAP-1 form a coopeative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev 15 (4):428-443
113. Groner AC, Meylan S, Ciuffi A, Zangger N, Ambrosini G, Denervaud N et al. (2010) KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet 6 (3):e1000869
114. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE et al. (2010) The Pfam protein families database. Nucleic Acids Res 38 (Database issue):211-222